O. Espinosa

534 total citations
24 papers, 376 citations indexed

About

O. Espinosa is a scholar working on Epidemiology, Molecular Biology and Genetics. According to data from OpenAlex, O. Espinosa has authored 24 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in O. Espinosa's work include Mesenchymal stem cell research (3 papers), Inflammatory Bowel Disease (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). O. Espinosa is often cited by papers focused on Mesenchymal stem cell research (3 papers), Inflammatory Bowel Disease (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). O. Espinosa collaborates with scholars based in Spain, United States and Cuba. O. Espinosa's co-authors include Guillermo T. Sáez, Felipe Javier Chaves, Antonio Iradi, Darius Lakdawalla, Seth A. Seabury, Ahva Shahabi, Sarah Green, Gary R. Lichtenstein, Robert N. Baldassano and M. Carmen Tormos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The American Journal of Gastroenterology.

In The Last Decade

O. Espinosa

20 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Espinosa Spain 11 93 70 66 63 49 24 376
Terry Law United States 11 84 0.9× 97 1.4× 53 0.8× 53 0.8× 36 0.7× 13 360
Marcial Martı́nez Spain 10 111 1.2× 57 0.8× 69 1.0× 99 1.6× 35 0.7× 22 509
Karolina Kędzierska Poland 11 86 0.9× 34 0.5× 43 0.7× 143 2.3× 20 0.4× 53 467
Kristine Jimenez Austria 10 75 0.8× 56 0.8× 32 0.5× 29 0.5× 138 2.8× 13 430
Xiaolong Yu China 14 122 1.3× 58 0.8× 77 1.2× 69 1.1× 38 0.8× 23 567
Flavia Di Bari Italy 15 58 0.6× 50 0.7× 50 0.8× 88 1.4× 15 0.3× 30 571
Sajini Elizabeth Jacob India 13 50 0.5× 15 0.2× 80 1.2× 67 1.1× 35 0.7× 42 375
Rita Maiavacca Italy 13 84 0.9× 14 0.2× 58 0.9× 48 0.8× 30 0.6× 26 340
W.-P. Koh Singapore 11 77 0.8× 120 1.7× 38 0.6× 96 1.5× 17 0.3× 13 598
William H. Vaughn United States 12 179 1.9× 74 1.1× 38 0.6× 90 1.4× 75 1.5× 16 856

Countries citing papers authored by O. Espinosa

Since Specialization
Citations

This map shows the geographic impact of O. Espinosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Espinosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Espinosa more than expected).

Fields of papers citing papers by O. Espinosa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Espinosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Espinosa. The network helps show where O. Espinosa may publish in the future.

Co-authorship network of co-authors of O. Espinosa

This figure shows the co-authorship network connecting the top 25 collaborators of O. Espinosa. A scholar is included among the top collaborators of O. Espinosa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Espinosa. O. Espinosa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jansen, Jeroen P., et al.. (2023). The Health Inequality Impact of a New Cancer Therapy Given Treatment and Disease Characteristics. Value in Health. 27(2). 143–152. 2 indexed citations
2.
Lichtenstein, Gary R, Ahva Shahabi, Seth A. Seabury, et al.. (2022). Increased Lifetime Risk of Intestinal Complications and Extraintestinal Manifestations in Crohn's Disease and Ulcerative Colitis.. PubMed. 18(1). 32–43. 11 indexed citations
3.
4.
Zerrweck, Carlos & O. Espinosa. (2020). Nuevas tecnologías y avances en terapias para la pérdida de peso. Revista de Gastroenterología de México. 85(4). 452–460. 2 indexed citations
5.
Zerrweck, Carlos & O. Espinosa. (2020). New technologies and advances in weight loss therapy. SHILAP Revista de lepidopterología. 85(4). 452–460.
6.
Jena, Anupam B., et al.. (2019). How Does Treating Chronic Hepatitis C Affect Individuals in Need of Organ Transplants in the United Kingdom?. Value in Health. 22(6). 669–676. 2 indexed citations
7.
Lichtenstein, Gary R., Ahva Shahabi, Seth A. Seabury, et al.. (2019). Lifetime Economic Burden of Crohn’s Disease and Ulcerative Colitis by Age at Diagnosis. Clinical Gastroenterology and Hepatology. 18(4). 889–897.e10. 73 indexed citations
8.
Sail, Kavita, et al.. (2017). Lifetime Costs of Patients with Chronic Lymphocytic Leukemia. Blood. 130. 5621–5621.
9.
Frasco, Melissa A., et al.. (2017). Incremental net monetary benefit of ocrelizumab relative to subcutaneous interferonβ-1a. Journal of Medical Economics. 20(10). 1074–1082. 13 indexed citations
10.
11.
Jurado, Manuel, Elisa López‐Fernández, O. Espinosa, et al.. (2017). Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study. Cytotherapy. 19(8). 927–936. 53 indexed citations
12.
Wang, Alice, et al.. (2017). Value of Comprehensive HCV Treatment among Vulnerable, High-Risk Populations. Value in Health. 20(6). 736–744. 14 indexed citations
13.
Lichtenstein, Gary R., Ahva Shahabi, Seth A. Seabury, et al.. (2017). Complications of Crohnʼs Disease and Ulcerative Colitis: Understanding the Lifetime Risks. The American Journal of Gastroenterology. 112. S395–S396. 2 indexed citations
14.
Fernández‐González, Ana, et al.. (2017). Optimization of an autologous human skin model under GMP guidelines. Cytotherapy. 19(5). S232–S233. 1 indexed citations
15.
Martínez‐Hervás, Sergio, José T. Real, O. Espinosa, et al.. (2008). Insulin resistance and oxidative stress in familial combined hyperlipidemia. Atherosclerosis. 199(2). 384–389. 31 indexed citations
16.
Martínez‐Hervás, Sergio, O. Espinosa, José T. Real, et al.. (2008). Estudio de los valores de 8-oxo-7,8-dihidro-2’-desoxiguanosina como marcador de estrés oxidativo del ADN en pacientes con hiperlipemia familiar combinada. Medicina Clínica. 131(1). 1–4. 11 indexed citations
17.
Espinosa, O., Jorge Jiménez, Felipe Javier Chaves, et al.. (2007). Urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxo-dG), a reliable oxidative stress marker in hypertension. Free Radical Research. 41(5). 546–554. 40 indexed citations
18.
Chaves, Felipe Javier, María Luisa Mansego, S. Blesa, et al.. (2006). Inadequate Cytoplasmic Antioxidant Enzymes Response Contributes to the Oxidative Stress in Human Hypertension. American Journal of Hypertension. 20(1). 62–69. 45 indexed citations
19.
Torres, José V., Carmen Tormos, Antonio Iradi, et al.. (2005). Impairment of antioxidant enzymes, lipid peroxidation and 8-oxo-2′-deoxyguanosine in advanced epithelial ovarian carcinoma of a Spanish community. Cancer Letters. 233(1). 28–35. 41 indexed citations
20.
Yuan, Joan, Thomas J. Goehl, Kamal M. Abdo, et al.. (1995). Effects of gavage versus dosed feed administration on the toxicokinetics of benzyl acetate in rats and mice. Food and Chemical Toxicology. 33(2). 151–158. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Terry Law Breakdown of academic impact, for papers by Marcial Martı́nez Breakdown of academic impact, for papers by Karolina Kędzierska Breakdown of academic impact, for papers by Kristine Jimenez Breakdown of academic impact, for papers by Xiaolong Yu Breakdown of academic impact, for papers by Flavia Di Bari Breakdown of academic impact, for papers by Sajini Elizabeth Jacob Breakdown of academic impact, for papers by Rita Maiavacca Breakdown of academic impact, for papers by W.-P. Koh Breakdown of academic impact, for papers by William H. Vaughn
Rankless by CCL
2026